A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Clinical trial NCT05382338 · RECRUITING

Trial details

NCT number: NCT05382338
Sponsor: Children's Oncology Group
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Childhood Medulloblastoma

Start date: 2023-02-20
Primary completion: 2029-12-31
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.